Dr. Josephine Bageritz

Heidelberg University
Centre for Organismal Studies (COS)
Junior Research Group: Stem Cell Niche Heterogeneity
Im Neuenheimer Feld 230
D-69120 Heidelberg

 

E-mail: Josephine.Bageritz@bioquant.uni-heidelberg.de

 

Homepage

Scientific CV

Academic education and professional career

since 2021
2015 - 2020
2014 - 2015
2013 - 2014

2013
2009

Independent junior research group leader, COS, Heidelberg University, Germany
Postdoc, German Cancer Research Center (DKFZ), Heidelberg, Germany
Postdoc, Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK
Postdoc, German Cancer Research Center (DKFZ), Heidelberg, Germany

Dr.rer.nat., Heidelberg University, Germany, Advisor: Prof. Peter Lichter
Diploma in Biology, Johannes Gutenberg University Mainz, Germany, Advisor: Prof. Erwin R. Schmidt/Prof. Peter Lichter

Other achievements & Awards

2020
 
 
11/2020
 
2017
2016 - 2018
2009 - 2012

Joint Coordinator of the Thematic Research Network (TRN) „SCiNetID – Single Cell Regulatory Networks in Development and Disease“ funded by the Excellence Strategy, Heidelberg University, Germany
Co-Organizer of the virtual international conference “Single Cell Regulatory Networks in Development and Disease”
Poster prize of the president of the German Genetics Society (GfG)
Postdoc Fellowship of the Fritz Thyssen foundation
Ph.D. Scholarship of the Helmholtz International Graduate School for Cancer Research, German Cancer Research Center (DKFZ), Heidelberg, Germany

Publications

  1. Ernst, K.J., K. Okonechnikov, J. Bageritz, J.P. Mallm, A. Wittmann, K.K. Maaß, S. Leible, M. Boutros, S.M. Pfister, M. Zuckermann, and D.T.W. Jones. 2020. Establishment of a simplified preparation method for single-nucleus RNA-sequencing and its application to long-term frozen tumor tissues. BioRxiv. https://doi.org/10.1101/2020.10.23.351809
  2. Bageritz, J., and G. Raddi. 2019. Single-Cell RNA Sequencing with Drop-Seq. In Single Cell Methods: Sequencing and Proteomics. V. Proserpio, editor. Springer New York, New York, NY. 73–85. PMID: 31028633
  3. Bageritz, J., P. Willnow, E. Valentini, S. Leible, M. Boutros, and A.A. Teleman. 2019. Gene expression atlas of a developing tissue by single cell expression correlation analysis. Nat. Methods. 16:750–756. PMID: 31363221
  4. Campos, B., S. Weisang, F. Osswald, R. Ali, G. Sedlmeier, J. Bageritz, J.-P. Mallm, C. Hartmann, A. von Deimling, O. Popanda, V. Goidts, C. Plass, A. Unterberg, P. Schmezer, J. Burhenne, and C. Herold-Mende. 2015. Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma. Glia. 63:1850–1859. PMID: 25944104
  5. Bageritz, J., and V. Goidts. 2014. Functional characterization of ENPP1 reveals a link between cell cycle progression and stem-like phenotype in glioblastoma. Molecular & Cellular Oncology. 1:e964028. PMID: 27308351
  6. Bageritz, J., L. Puccio, R.M. Piro, V. Hovestadt, E. Phillips, T. Pankert, J. Lohr, C. Herold-Mende, P. Lichter, and V. Goidts. 2014. Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1. Cell Death & Differentiation. 21:929–940. PMID: 24531536
  7. Campos, B., Z. Gal, A. Baader, T. Schneider, C. Sliwinski, K. Gassel, J. Bageritz, N. Grabe, A. von Deimling, P. Beckhove, C. Mogler, V. Goidts, A. Unterberg, V. Eckstein, and C. Herold-Mende. 2014. Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma. The Journal of Pathology. 234:23–33. PMID: 24756862
  8. Nakata, S., B. Campos, J. Bageritz, J. Lorenzo Bermejo, N. Becker, F. Engel, T. Acker, S. Momma, C. Herold-Mende, P. Lichter, B. Radlwimmer, and V. Goidts. 2013. LGR5 is a Marker of Poor Prognosis in Glioblastoma and is Required for Survival of Brain Cancer Stem-Like Cells. Brain Pathology. 23:60–72. PMID: 22805276
  9. Goidts, V., J. Bageritz, L. Puccio, S. Nakata, M. Zapatka, S. Barbus, G. Toedt, B. Campos, A. Korshunov, S. Momma, E. Van Schaftingen, G. Reifenberger, C. Herold-Mende, P. Lichter, and B. Radlwimmer. 2012. RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival. Oncogene. 31:3235–3243. PMID: 22056879
  10. Gronych, J., A. Korshunov, J. Bageritz, T. Milde, M. Jugold, D. Hambardzumyan, M. Remke, C. Hartmann, H. Witt, D.T.W. Jones, O. Witt, S. Heiland, M. Bendszus, E.C. Holland, S. Pfister, and P. Lichter. 2011. An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice. J Clin Invest. 121:1344–1348. PMID: 21403401